What does it cost?
A single IV session in Nevada typically runs $450 to $500, and a first course is usually six sessions. Spravato is different, because it is normally billed through insurance.
If you are in crisis, help is available now. Call or text 988 to reach the Suicide & Crisis Lifeline, or text HOME to 741741. If someone is in immediate danger, call 911. This site is information only and cannot provide urgent help.
Independent, sourced information for people in Las Vegas, Henderson, North Las Vegas and across Nevada — written for patients and families, and dated so you can see how current it is.
What it costs in Nevada Does Nevada Medicaid and Nevada Check Up cover it?
This is an independent information resource. We are not a clinic, not a treatment provider, and not a REMS-certified facility. We cannot book appointments or make referrals. No clinic pays to be listed here.
Answer a few questions and we will show a range — or tell you plainly when we cannot give you a number worth having. Nothing you choose is sent anywhere, and there is nothing to sign up for.
Based on published pricing and coverage rules as of 2019-03-05. Sources for every figure this tool can show:
Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 1, opens in a new tab)
Under Original Medicare Part B in 2026 you pay a $283 yearly deductible first, and after that you generally pay 20% of the Medicare-approved amount for covered services. as of 1 Jan 2026 · Centers for Medicare and Medicaid Services (source 2, opens in a new tab)Deductible and premium amounts are set annually and change each January.
Nevada Medicaid and Nevada Check Up list Spravato as a preferred medicine in the 'Antidepressants: Other' class, with prior approval required. Nevada moved to a single preferred drug list covering both fee-for-service and all managed care plans from January 2026. as of 1 Nov 2025 · Nevada Medicaid (source 3, opens in a new tab)A newer revision of the list may exist that we could not retrieve. Note that Spravato carries only a prior-approval flag — despite what some summaries say, the published list applies no specialty-pharmacy or Spravato-specific quantity flag.
Best available information: No Nevada clinic we checked publishes a price for intramuscular ketamine, though several offer it. We have no Nevada figure, and the ranges quoted by national directories are not Nevada data. as of 18 Jul 2026 · Klarity Clinic (source 5, opens in a new tab)We would rather tell you we do not know than repeat a figure we cannot trace to a Nevada clinic.
Nevada clinics that publish their prices charge roughly $450 to $500 for a single IV ketamine infusion for depression. Sessions that bundle psychotherapy run higher, up to around $750, and longer infusions used for chronic pain are priced separately. as of 18 Jul 2026 · Published Nevada clinic price lists (source 6, opens in a new tab)Based on three Nevada clinics across both metro areas. Some clinics offer reduced rates for veterans and first responders — worth asking.
Best available information: At-home oral ketamine is sold to Nevada residents by national telehealth companies in prepaid multi-session packages — around $499 for four sessions, or $792 for eight, including the medicine, telehealth appointments and coaching. No Nevada clinic publishes lozenge pricing. as of 18 Jul 2026 · Better U (source 7, opens in a new tab)This is a national company charging the same price everywhere, not a Nevada market rate. It is sold only as a package — a single session is not purchasable at the per-session figure.
Best available information: No Nevada clinic we checked publishes a self-pay price for Spravato. Every Nevada provider we looked at routes pricing through an insurance check first, so a self-pay patient has to ask for an individual quote. as of 18 Jul 2026 · Published Nevada clinic Spravato pages (source 8, opens in a new tab)Our estimator does not produce a self-pay Spravato figure, because there is no Nevada evidence strong enough to build one on.
The FDA approved Spravato (esketamine) nasal spray on 5 March 2019, for use with an oral antidepressant, for adults with treatment-resistant depression. as of 5 Mar 2019 · U.S. Food and Drug Administration (source 11, opens in a new tab)
Spravato is available only through a restricted safety programme called a Risk Evaluation and Mitigation Strategy (REMS), and may only be given in a certified healthcare setting under a provider's direct observation. Patients never take it home. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 14, opens in a new tab)
Best available information: Spravato's list price is not published by the manufacturer or in any free public source. At launch in 2019 the wholesale acquisition cost was around $590 for a 56 mg dose and $885 for an 84 mg dose, and the current list price is very likely higher. as of 5 Mar 2019 · Drugs.com (source 15, opens in a new tab)Wholesale acquisition cost is published only in paywalled pricing compendia. The figures here are seven years old and come from a secondary source, so we do not use them to produce a dollar estimate — the estimator suppresses Spravato cash figures rather than presenting a number this weak.
The Spravato withMe savings programme is not available to anyone using a state or federal government health programme, including Medicare, Medicaid, TRICARE, the Department of Defense, and the Veterans Administration. as of 18 Jul 2026 · Johnson & Johnson (source 16, opens in a new tab)
Through the Spravato withMe savings programme, eligible patients with commercial insurance may pay as little as $10 per treatment for the medicine itself, subject to yearly maximum benefits and quantity limits. as of 18 Jul 2026 · Johnson & Johnson (source 17, opens in a new tab)The programme covers the medicine, not the office visit or the two-hour observation, which is often the larger share of the bill. The official terms state that a yearly maximum applies but do not publish the amount, so we do not either. Terms are set per calendar year.
A single IV session in Nevada typically runs $450 to $500, and a first course is usually six sessions. Spravato is different, because it is normally billed through insurance.
Spravato is generally covered with prior approval, including by Nevada Medicaid and Nevada Check Up. IV ketamine is off-label and almost never covered, whoever your insurer is.
We list 49 clinicians registered in Nevada whose specialty is associated with ketamine therapy — and we are clear about what that does and does not tell you.
| Treatment | FDA status | Where and how long | Typical course | Insurance | Driving | Typical cash cost |
|---|---|---|---|---|---|---|
| IV ketamine infusion | Not FDA-approved for depression (off-label) | In a clinic, usually 40–60 minutes plus recovery | Typically six sessions over two to three weeks | Almost never covered | You will need someone to drive you home | $450–$500 |
| Spravato (esketamine) | FDA-approved for treatment-resistant depression | Self-administered nasal spray in a certified clinic, with two hours of monitoring | Twice weekly for four weeks, then less often | Usually billed through insurance, with prior approval | No driving until the next day, after a night of restful sleep | Depends on your coverage |
| IM injection | Not FDA-approved for depression (off-label) | In a clinic, shorter than an infusion | Varies by clinic | Almost never covered | You will need someone to drive you home | $300–$600 |
| Sublingual or lozenge | Not FDA-approved for depression (off-label) | At home, or in a supervised session | Varies widely by programme | Almost never covered | Do not drive after a dose | $99–$125 |
Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 1, opens in a new tab)
Nevada clinics that publish their prices charge roughly $450 to $500 for a single IV ketamine infusion for depression. Sessions that bundle psychotherapy run higher, up to around $750, and longer infusions used for chronic pain are priced separately. as of 18 Jul 2026 · Published Nevada clinic price lists (source 6, opens in a new tab)Based on three Nevada clinics across both metro areas. Some clinics offer reduced rates for veterans and first responders — worth asking.
Best available information: No Nevada clinic we checked publishes a price for intramuscular ketamine, though several offer it. We have no Nevada figure, and the ranges quoted by national directories are not Nevada data. as of 18 Jul 2026 · Klarity Clinic (source 5, opens in a new tab)We would rather tell you we do not know than repeat a figure we cannot trace to a Nevada clinic.
Best available information: At-home oral ketamine is sold to Nevada residents by national telehealth companies in prepaid multi-session packages — around $499 for four sessions, or $792 for eight, including the medicine, telehealth appointments and coaching. No Nevada clinic publishes lozenge pricing. as of 18 Jul 2026 · Better U (source 7, opens in a new tab)This is a national company charging the same price everywhere, not a Nevada market rate. It is sold only as a package — a single session is not purchasable at the per-session figure.
After a Spravato dose you must not drive or operate machinery until the next day, following a restful night's sleep, so you need to arrange a ride home from every session. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 13, opens in a new tab)
Clark County holds roughly three-quarters of Nevada's population, so the Las Vegas, Henderson and North Las Vegas corridor is where nearly all of the state's ketamine and Spravato capacity sits.
Las Vegas · Henderson · North Las Vegas
Reno, Sparks and neighbouring Carson City form the state's second care hub, anchored by Renown Health and the University of Nevada, Reno School of Medicine.
Reno · Sparks · Carson City
Eleven of Nevada's seventeen counties are federally designated frontier and three more are rural, together covering about 87% of the state's land area but a small share of its people.
Elko
Nevada's two care hubs are about 448 miles and seven and a half hours apart by road, and Elko sits roughly four and a half hours from Reno. Outside Clark and Washoe counties, multi-hour one-way drives to reach a ketamine or Spravato provider are normal — and a course of infusions, or twice-weekly Spravato induction visits, means making that trip again and again, with someone else driving you home each time.
Nevada borders CA, OR, ID, UT, AZ. A clinic across the border may be closer than one in your own state — but check that it is in your insurance network first, and note that a clinician must be licensed where you receive care.
Nevada advanced practice registered nurses have full practice authority: they may diagnose, treat and prescribe without physician supervision or a collaborative agreement, and because ketamine is Schedule III an APRN may prescribe it independently once controlled-substance registration is granted. Certified registered nurse anaesthetists are treated differently — Nevada law bars a CRNA from ordering or prescribing controlled substances except under physician supervision in a critical access hospital or a hospital in a town under 25,000 people, so in a Las Vegas or Reno clinic a CRNA may only administer ketamine on another prescriber's order. as of 18 Jul 2026 · Nevada Legislature (source 1, opens in a new tab)Nevada's two-year or 2,000-hour experience threshold applies to Schedule II prescribing only. Ketamine is Schedule III, so that threshold does not affect it.
Nevada Medicaid and Nevada Check Up list Spravato as a preferred medicine in the 'Antidepressants: Other' class, with prior approval required. Nevada moved to a single preferred drug list covering both fee-for-service and all managed care plans from January 2026. as of 1 Nov 2025 · Nevada Medicaid (source 1, opens in a new tab)A newer revision of the list may exist that we could not retrieve. Note that Spravato carries only a prior-approval flag — despite what some summaries say, the published list applies no specialty-pharmacy or Spravato-specific quantity flag.
On 17 January 2025 the FDA approved Spravato for treatment-resistant depression in adults either on its own or together with an oral antidepressant, so a companion oral antidepressant is now optional for this use — though it is still permitted. as of 17 Jan 2025 · U.S. Food and Drug Administration (source 3, opens in a new tab)This applies to the treatment-resistant depression indication only. The separate indication for major depressive disorder with acute suicidal ideation still requires an oral antidepressant — see spravato.approval_mdd_si. Widely-cited secondary sources give 21 January 2025; that is the manufacturer's announcement date, not the FDA action date on the approval letter.
After a Spravato dose you must not drive or operate machinery until the next day, following a restful night's sleep, so you need to arrange a ride home from every session. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 4, opens in a new tab)
Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 1, opens in a new tab)
Nevada does not require an in-person examination before prescribing controlled substances by telehealth. State law allows the patient relationship to be established by telehealth where that is clinically appropriate, and treats the relationship as valid if you were examined in person or by telehealth within the previous six months. The clinician must hold a Nevada licence. as of 18 Jul 2026 · Nevada Legislature (source 4, opens in a new tab)Federal DEA telemedicine flexibilities run separately and expire at the end of 2026, and they require video — audio-only does not qualify for ketamine. Spravato cannot be prescribed for home use in any case.
Partly, and Nevada is stricter here than several neighbouring states. Ketamine is Schedule III in Nevada, and Schedule III sits squarely inside the state's check requirement — so if a clinician writes you a ketamine prescription to take away, they must run the report first and again every ninety days. Whether the requirement reaches an infusion given entirely inside a clinic is unsettled, because the duty is written around issuing a prescription rather than administering a dose. as of 18 Jul 2026 · Nevada Legislature (source 3, opens in a new tab)No Nevada board guidance or court decision resolves the in-clinic administration question, so we do not present either answer as settled.
Nevada advanced practice registered nurses have full practice authority: they may diagnose, treat and prescribe without physician supervision or a collaborative agreement, and because ketamine is Schedule III an APRN may prescribe it independently once controlled-substance registration is granted. Certified registered nurse anaesthetists are treated differently — Nevada law bars a CRNA from ordering or prescribing controlled substances except under physician supervision in a critical access hospital or a hospital in a town under 25,000 people, so in a Las Vegas or Reno clinic a CRNA may only administer ketamine on another prescriber's order. as of 18 Jul 2026 · Nevada Legislature (source 4, opens in a new tab)Nevada's two-year or 2,000-hour experience threshold applies to Schedule II prescribing only. Ketamine is Schedule III, so that threshold does not affect it.
Everything Nevada residents need to know about ketamine therapy in 2026: how it works, who oversees clinics, and how to find licensed providers.
Not all Nevada ketamine clinics are alike. Here are the key questions to ask before choosing a provider — covering licensure, safety protocols, and cost.
What Nevada patients need to know about Spravato insurance coverage in 2026: Anthem Blue Cross, Nevada Medicaid prior auth, and how to navigate the process.